‘COVAXIN® Proven SAFE in India’s Largest Efficacy Trial. Final Phase-3 Pre-Print Data Published…’ -Tweet From Ocugen COVID-19 Vaccine Partner, Bharat
https://twitter.com/BharatBiotech/status/1411054740713086979
Lundbeck Out Licenses Flopped Alzheimer’s Drug In Wake Of Biogen’s Controversial Success With Aducanumab
Privately-held Denovo Biopharma LLC has in-licensed global rights for idalopirdine from H. Lundbeck A/S (OTC:HLUYY) for all indications. The deal gives Lundbeck the option…
Teva Recalls One Batch Of Topotecan After Complaint Of Glass Particulate In Vial
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is recalling one lot of its cancer drug topotecan injection after a pharmacy complaint flagged the presence of a single glass particulate in a vial of the drug.
ReShape Lifesciences Granted European Patent Titled, ‘ULTRASONIC SYSTEMS AND METHODS FOR LOCATING AND/OR CHARACTERIZING INTRAGASTRIC DEVICES’
https://register.epo.org/application?number=EP15849671
CEL-SCI Says Results Of Co’s Phase 3 Trial Now Available
CEL-SCI Corporation (NYSE:CVM) today announced that the discussion at the Annual Shareholder Meeting, on July 1, 2021 at 10:00 am EDT, regarding its Phase 3 head and neck cancer trial results is available